- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
For the first time in decades, new drugs and therapies that may provide real relief for anyone living with eczema are close to being available. For many, this is a time of unprecedented hope. But what if there were a way to prevent the very first flare, to stop eczema from even starting? Frustrated by seeing patients with eczema […]
A recent survey conducted by the National Eczema Association (NEA) in early September revealed at more than 20% of parents and caregivers who responded indicated their children experienced bullying at school, during extracurricular activities or with friends because of eczema. The Dermatology Times highlighted this difficult problem in a recent article, Survey puts spotlight on […]
PRESS RELEASE One in five children with eczema will be bullied this school year due to their disease, according to the National Eczema Association San Rafael, California, September 7, 2016 – Results from a new National Eczema Association (NEA) survey of eczema parents and caregivers show that at least one in five children with eczema, including […]
Understanding AD’s impact to improve your quality of life People living with atopic dermatitis (AD), the most common and chronic form of eczema, know first-hand the burden AD has on both individuals and families. The impacts reach far beyond the serious effects of the disease symptoms such as itch, pain, and inflammation –they also include […]
We asked, you answered. The verdict? People living with eczema want more information and more options. This past January, many of you responded to a 6-question online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis (AD). We learned that the vast majority of […]
June 9, 2016 – On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported positive results for the Phase 3 the clinical trial of the new biologic drug, dupilumab, when used in conjunction with a topical corticosteroid by adults to treat moderate-to-severe atopic dermatitis (AD).
January 11, 2016 – We need to hear from you! We are launching a series of short surveys to make certain we best understand the challenges you face with eczema. Together, we will use this information to fight for your needs, whether you’re an adult with eczema, a child, or parent on the eczema journey. The information you share will shape NEA’s policy priorities for 2016 and beyond, and help us better tell the collective stories about the impact eczema has on your lives.
November 3, 2015 – A research team at Emory University was awarded a NEA Research Grant for their pilot study of the efficacy of meditation for treatment of chronic pruritus (itch). Following is an interview about the study and results, with investigators Mamta Javari, MD, and Suephy Chen, MD.
September 21 – The National Eczema Association (NEA) has awarded Dr. Aaron Drucker, Assistant Professor, Department of Dermatology at Brown University, with the NEA Burden of Disease Research Audit grant, the findings of which will help to raise the profile of eczema as a serious disease, to deliver stronger, more united messages to insurers, medical providers and policy-makers on behalf of the eczema community.
August 3, 2015 – Eczema is the same in any country, in any language. Enjoy this video from our friends in Brazil and share it if you can relate to this family’s story.